Merce Obach
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Reporting reimbursement price decisions for onco-hematology drugs in Spain.
Journal: Frontiers in public health
Published: July 22, 2023
Financing and Reimbursement of Approved Advanced Therapies in Several European Countries.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: May 28, 2022
Early Access to Medicines: Use of Multicriteria Decision Analysis (MCDA) as a Decision Tool in Catalonia (Spain).
Journal: Journal of clinical medicine
Published: January 20, 2022
Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union.
Journal: Frontiers in pharmacology
Published: September 10, 2021
Current landscape of clinical development and approval of advanced therapies.
Journal: Molecular therapy. Methods & clinical development
Published: June 04, 2021
Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies.
Journal: BMC health services research
Published: February 11, 2021
Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.
Journal: Frontiers in pharmacology
Published: April 20, 2020
Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
Journal: Molecular metabolism
Published: March 12, 2020
Hurdles of environmental risk assessment procedures for advanced therapy medicinal products: comparison between the European Union and the United States.
Journal: Critical reviews in toxicology
Published: December 18, 2019
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.
Journal: Applied health economics and health policy
Published: November 07, 2019
Last Updated: 09/26/2026